<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03711006</url>
  </required_header>
  <id_info>
    <org_study_id>16049117</org_study_id>
    <nct_id>NCT03711006</nct_id>
  </id_info>
  <brief_title>The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis</brief_title>
  <official_title>The Effect of Fecal Microbiota Transplantation in Ulcerative Colitis - A Case Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alice Højer Christensen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aleris-Hamlet Hospitaler København</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      7 patients with active Ulcerative Colitis are treated with 25 multi-donor FMT Capsules daily
      for 50 days.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      7 patients with active Ulcerative Colitis are treated with 25 multi-donor FMT Capsules daily
      for 50 days All patients are followed with regular follow up after 2,4,8,12,16, 20 and 24
      weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">November 30, 2017</completion_date>
  <primary_completion_date type="Actual">November 30, 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The trial is an open-label pilot study treating 7 patients with Ulcerative Colitis with 25 daily multi-donor FMT Capsules for 50 days with 6 months follow up including the treatment period</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in patient colitis symptoms as assessed using the Simple Colitis Clinical Activity Index (SCCAI)</measure>
    <time_frame>Baseline, 2,8,16 and 24 weeks</time_frame>
    <description>Simple Colitis Clinical Activity Index (SCCAI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fecal microbiota biodiversity in patients with Ulcerative Colitis and difference to donors fecal microbiota diversity</measure>
    <time_frame>Baseline</time_frame>
    <description>Alpha diversity (Shannon-index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal microbiota biodiversity in fecal donors</measure>
    <time_frame>At donor inclusion</time_frame>
    <description>Alpha diversity (Shannon-index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in fecal microbiota biodiversity in patients with Ulcerative Colitis in comparison with value at baseline</measure>
    <time_frame>8, 16 and 24 weeks</time_frame>
    <description>Alpha diversity (Shannon-index)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Fecal Calprotectin in the active treatment period and follow-up period</measure>
    <time_frame>Baseline, 8,16 and 24 weeks</time_frame>
    <description>Fecal Calprotectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in patient reported quality of life: IBDQ</measure>
    <time_frame>Baseline, 8, 16 and 24 weeks</time_frame>
    <description>Inflammatory Bowel Disease Questionnaire (IBDQ)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>FMT treated patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Seven patients with active Ulcerative Colitis treated with 25 multi-donor FMT Capsules daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fecal Microbiota Transplantation Capsules</intervention_name>
    <description>25 daily multi-donor FMT Capsules for 50 days</description>
    <arm_group_label>FMT treated patients</arm_group_label>
    <other_name>FMT Capsules</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with Ulcerative Colitis (UC)

          -  SCCAI between 4 and 10 at inclusion

          -  On a stable dose of 5-aminosalicylic acid (5-ASA) or without current treatment.

          -  Previous treatment with glucocorticoids, thiopurines and/or biological treatment was
             accepted.

          -  Fecal Calprotectin &gt; 250 mg/kg

          -  Colonoscopy performed within the last 3 years

          -  Capable of writing and speaking Danish

          -  Attending regular follow-ups by a specialist in gastroenterology.

        Exclusion Criteria:

          -  Biological treatment within the last four weeks

          -  Treatment with antibiotics within 48 hours before intervention

          -  Alcohol use above current Danish guidelines (14 units/week for men and 7 units/week
             for women)

          -  Pregnancy or planned pregnancy

          -  Active cancer disease

          -  Medical treatment of mental disorder

          -  Other chronic gastroenterological disorder besides UC, Irritable Bowel Syndrome (IBS)
             or Reflux-disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alice H Christensen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aleris-Hamlet Hospitals Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aleris-Hamlet Hospital Copenhagen</name>
      <address>
        <city>Søborg</city>
        <zip>2860</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>October 10, 2018</study_first_submitted>
  <study_first_submitted_qc>October 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2018</study_first_posted>
  <last_update_submitted>October 17, 2018</last_update_submitted>
  <last_update_submitted_qc>October 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Aleris-Hamlet Hospitaler København</investigator_affiliation>
    <investigator_full_name>Alice Højer Christensen</investigator_full_name>
    <investigator_title>Principal Investigator, MD, Ph.d., Senior Specialist in Medical Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Fecal Microbiota Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data are available upon request</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>April 25, 2019</submitted>
    <returned>July 10, 2019</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

